MIRM FY 2022 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+302.7% YoY

Gross Profit

$65M83.9% margin

Operating Income

-$131M-170.3% margin

Net Income

-$136M-176.0% margin

EPS (Diluted)

$-4.02

Cash Flow

Operating Cash Flow

-$120M

Free Cash Flow

-$120M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$353M

Total Liabilities

$211M

Stockholders' Equity

$142M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$19M	+302.7%
Gross Profit	$65M	$17M	+275.3%
Operating Income	-$131M	-$173M	+24.3%
Net Income	-$136M	-$84M	-61.5%